BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34898169)

  • 21. Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics.
    Zheng X; Zhang F; Zhao Y; Zhang J; Dawulieti J; Pan Y; Cui L; Sun M; Shao D; Li M; He K; Zhang M; Li J; Chen L
    Theranostics; 2018; 8(14):3808-3823. PubMed ID: 30083261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs.
    Velagapudi SP; Costales MG; Vummidi BR; Nakai Y; Angelbello AJ; Tran T; Haniff HS; Matsumoto Y; Wang ZF; Chatterjee AK; Childs-Disney JL; Disney MD
    Cell Chem Biol; 2018 Sep; 25(9):1086-1094.e7. PubMed ID: 30251629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
    Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
    Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells.
    Zhang S; Ma C; Pang H; Zeng F; Cheng L; Fang B; Ma J; Shi Y; Hong H; Chen J; Wang Z; Xia J
    Biochem Biophys Res Commun; 2016 Jan; 469(1):55-61. PubMed ID: 26592661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folate inhibits miR-27a-3p expression during cervical carcinoma progression and oncogenic activity in human cervical cancer cells.
    Wang Z; Wang W; Zhao W; Wang Z; Yang J; Wang W; Teng P; Su X; Li D; Zhang X; Wang H; Hao M
    Biomed Pharmacother; 2020 Feb; 122():109654. PubMed ID: 31918266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages.
    Yao X; Tu Y; Xu Y; Guo Y; Yao F; Zhang X
    J Cell Mol Med; 2020 Sep; 24(17):9560-9573. PubMed ID: 32672418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
    Chintharlapalli S; Papineni S; Abdelrahim M; Abudayyeh A; Jutooru I; Chadalapaka G; Wu F; Mertens-Talcott S; Vanderlaag K; Cho SD; Smith R; Safe S
    Int J Cancer; 2009 Oct; 125(8):1965-74. PubMed ID: 19582879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.
    Chiyomaru T; Yamamura S; Zaman MS; Majid S; Deng G; Shahryari V; Saini S; Hirata H; Ueno K; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Nakagawa M; Dahiya R
    PLoS One; 2012; 7(8):e43812. PubMed ID: 22928040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA-27a-3p but Not -5p Is a Crucial Mediator of Human Adipogenesis.
    Wu H; Pula T; Tews D; Amri EZ; Debatin KM; Wabitsch M; Fischer-Posovszky P; Roos J
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coordinated targeting of the EGFR signaling axis by microRNA-27a*.
    Wu X; Bhayani MK; Dodge CT; Nicoloso MS; Chen Y; Yan X; Adachi M; Thomas L; Galer CE; Jiffar T; Pickering CR; Kupferman ME; Myers JN; Calin GA; Lai SY
    Oncotarget; 2013 Sep; 4(9):1388-98. PubMed ID: 23963114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
    Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
    Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of Anti-Proliferative and Apoptotic Effects of Sorafenib Using miR-27a Inhibitor in Hepatocellular Carcinoma Cell Lines.
    Abdel Wahab AHA; Ayad EG; Abdulla MS; Sharada HM; Ashmawy AM
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2951-2958. PubMed ID: 34582667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-27a-3p Downregulation Inhibits Inflammatory Response and Hippocampal Neuronal Cell Apoptosis by Upregulating Mitogen-Activated Protein Kinase 4 (MAP2K4) Expression in Epilepsy: In Vivo and In Vitro Studies.
    Lu J; Zhou N; Yang P; Deng L; Liu G
    Med Sci Monit; 2019 Nov; 25():8499-8508. PubMed ID: 31710596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands.
    Liu X; Haniff HS; Childs-Disney JL; Shuster A; Aikawa H; Adibekian A; Disney MD
    J Am Chem Soc; 2020 Apr; 142(15):6970-6982. PubMed ID: 32233464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.
    Chari NS; Ivan C; Le X; Li J; Mijiti A; Patel AA; Osman AA; Peterson CB; Williams MD; Pickering CR; Caulin C; Myers JN; Calin GA; Lai SY
    J Natl Cancer Inst; 2020 Mar; 112(3):266-277. PubMed ID: 31124563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct microRNA expression pattern in breast cancer cells following anti-neoplastic treatment: A systematic review and functional analysis of microRNA target genes.
    Qatrun Nada D; Masniza ML; Abdullah N; Marlini M; Elias MH; Pathmanathan SG; Hayati AR; Fadlul Azim F; Hamid AA; Nur Fariha MM
    Malays J Pathol; 2022 Dec; 44(3):367-385. PubMed ID: 36591707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
    Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
    Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions.
    Pinatel EM; Orso F; Penna E; Cimino D; Elia AR; Circosta P; Dentelli P; Brizzi MF; Provero P; Taverna D
    PLoS One; 2014; 9(1):e84859. PubMed ID: 24400121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.